5 Key Challenges and Opportunities for Medically Integrated Dispensing Pharmacies in 2025
2 Articles
2 Articles
2025 promises difficulties (but also opportunities)
The main challenges for 2025 and the political and economic trends that will mark the coming times, both nationally and internationally, were the focus of a new Fora da Caixa Meeting, organized by Caixa Geral de Depósitos with Expresso as media partner
5 Key Challenges and Opportunities for Medically Integrated Dispensing Pharmacies in 2025
In 2025, medically integrated dispensing pharmacies face significant challenges, including low reimbursements, restrictive pharmacy benefit manager practices, complex therapies, regulatory barriers such as the Stark delivery law, and the Inflation Reduction Act's financial implications, necessitating urgent advocacy, reform, and collaboration to sustain equitable, patient-centered cancer care.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage